How NIH’s Financial Conflict of Interest Rules Are Expanding Institutional Risk in 2026
NIH’s financial conflict of interest rules are placing greater pressure on institutions to strengthen disclosure oversight and compliance systems.
Category: Knowledge is Power
On Wednesdays, sharing best practices, tips, anything that shows our expertise.
How NIH’s New eRA Commons Account Consolidation Feature Could Reduce Administrative Friction
NIH’s new eRA Commons account consolidation feature aims to simplify login management and reduce administrative burden across research institutions.
Essential Steps for Funding Success Without Sacrificing Control
Grow your startup without giving up IP or ownership rights! 💡📈 Discover strategies like bootstrapping, non-dilutive funding, and strategic partnerships. 🚀
NIH’s Replication and Reproducibility Focus Is Reshaping How Strong Applications Are Recognized
NIH is reinforcing reproducibility expectations, shifting how reviewers assess credibility and forcing applicants to rethink how rigor is built into study design.
Using AI for Grant Writing Is Easy; Getting Funded Still Takes a Human
AI speeds up grant writing, but misalignment with agency expectations remains the quiet reason many strong proposals fail to secure funding.
How to Think About AI, IP, and Funding Before Your Startup Is Under Review
AI strengthens proposals only when ownership is clear. Reviewers focus on IP, data rights, and commercialization risk, not technical buzzwords.
How to Approach SBIR/STTR Resubmissions When the Rules Have ChangedWhy You Should Plan on Resubmitting SBIR proposals After Rejection
SBIR resubmissions are still allowed, but success depends on correcting reviewer concerns, not simply revising language or adding more detail.
SBIR/STTR TABA Changes: More Than a Minor Budget Update
The new SBIR/STTR TABA rules change who can use funds, how they can be used, and why proposal strategy matters more.
Evaluation in SBIR/STTR Post 2026
SBIR is reauthorized. Heightened oversight makes independent evaluation a strategic advantage for applicants in upcoming funding cycles
What “Competitive But Not Discussed” Really Signals in NIH Review, and What to Do With It
NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.